Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

BioNTech SE, Common Stock

BNTX

NSQ

$87.01

-$1.64

(-1.85%)

Industry: Biotechnology Sector: Health Care

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$20.68B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

20.52

Volume

This is the total number of shares traded during the most recent trading day.

574.54K

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

645.09K

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.23

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$85.21 L

$131.52 H

$87.01

About BioNTech SE, Common Stock

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT114 to treat triple negative breast cancer; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors; BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I/II clinical trial to treat multiple solid tumors; and BNT312, which is in Phase 2 clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase III clinical trial to treat ovarian cancer and Phase I/II clinical trial to treat multiple solid tumors. It develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I/Ib clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. It has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany. more

Industry: BiotechnologySector: Health Care

Returns

Time Frame	BNTX	Sector	S&P500;
1-Week Return	-3.26%	-0.25%	0.25%
1-Month Return	-9.65%	-2.9%	0.89%
3-Month Return	-16.08%	0.87%	8.31%
6-Month Return	-21.57%	9.38%	18.76%
1-Year Return	-31.13%	7.5%	27.47%
3-Year Return	-27.45%	25.66%	30.79%
5-Year Return	519.12%	70.29%	93.94%

Time Frame	BNTX	Sector	S&P500;
1-Week Return	-82.24%	-12.24%	13.90%
1-Month Return	-70.91%	-30.10%	11.38%
3-Month Return	-50.88%	3.58%	38.23%
6-Month Return	-38.90%	19.94%	41.71%
1-Year Return	-31.13%	7.50%	27.47%
3-Year Return	-10.14%	7.91%	9.36%
5-Year Return	44.00%	11.23%	14.17%

Financials

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	108.59M	482.32M	18.98B	17.31B	3.82B	[{"date":"2019-12-31","value":0.57,"profit":true},{"date":"2020-12-31","value":2.54,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.22,"profit":true},{"date":"2023-12-31","value":20.12,"profit":true}]
Cost of Revenue	243.83M	704.36M	3.86B	4.53B	599.80M	[{"date":"2019-12-31","value":5.38,"profit":true},{"date":"2020-12-31","value":15.54,"profit":true},{"date":"2021-12-31","value":85.19,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":13.23,"profit":true}]
Gross Profit	(135.24M)	(222.04M)	15.12B	12.78B	3.22B	[{"date":"2019-12-31","value":-0.89,"profit":false},{"date":"2020-12-31","value":-1.47,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.54,"profit":true},{"date":"2023-12-31","value":21.3,"profit":true}]
Gross Margin	(124.54%)	(46.03%)	79.66%	73.82%	84.29%	[{"date":"2019-12-31","value":-147.75,"profit":false},{"date":"2020-12-31","value":-54.61,"profit":false},{"date":"2021-12-31","value":94.5,"profit":true},{"date":"2022-12-31","value":87.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	46.28M	(139.62M)	200.10M	135.90M	2.31B	[{"date":"2019-12-31","value":2,"profit":true},{"date":"2020-12-31","value":-6.03,"profit":false},{"date":"2021-12-31","value":8.64,"profit":true},{"date":"2022-12-31","value":5.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(181.52M)	(82.42M)	15.28B	12.64B	690.40M	[{"date":"2019-12-31","value":-1.19,"profit":false},{"date":"2020-12-31","value":-0.54,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":82.72,"profit":true},{"date":"2023-12-31","value":4.52,"profit":true}]
Total Non-Operating Income/Expense	1.81M	(66.87M)	(263.20M)	622.80M	281.90M	[{"date":"2019-12-31","value":0.29,"profit":true},{"date":"2020-12-31","value":-10.74,"profit":false},{"date":"2021-12-31","value":-42.26,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":45.26,"profit":true}]
Pre-Tax Income	(179.44M)	(145.80M)	15.05B	12.95B	1.19B	[{"date":"2019-12-31","value":-1.19,"profit":false},{"date":"2020-12-31","value":-0.97,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.09,"profit":true},{"date":"2023-12-31","value":7.88,"profit":true}]
Income Taxes	(268.00K)	(161.00M)	4.75B	3.52B	255.80M	[{"date":"2019-12-31","value":-0.01,"profit":false},{"date":"2020-12-31","value":-3.39,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.04,"profit":true},{"date":"2023-12-31","value":5.38,"profit":true}]
Income After Taxes	(179.17M)	15.20M	10.29B	9.43B	930.30M	[{"date":"2019-12-31","value":-1.74,"profit":false},{"date":"2020-12-31","value":0.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.66,"profit":true},{"date":"2023-12-31","value":9.04,"profit":true}]

Income From Continuous Operations	(179.17M)	15.20M	10.29B	9.43B	930.30M	[{"date":"2019-12-31","value":-1.74,"profit":false},{"date":"2020-12-31","value":0.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.66,"profit":true},{"date":"2023-12-31","value":9.04,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(179.17M)	15.20M	10.29B	9.43B	930.30M	[{"date":"2019-12-31","value":-1.74,"profit":false},{"date":"2020-12-31","value":0.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.66,"profit":true},{"date":"2023-12-31","value":9.04,"profit":true}]

EPS (Diluted)	(0.39)	0.07	39.69	36.93	3.89	[{"date":"2019-12-31","value":-0.98,"profit":false},{"date":"2020-12-31","value":0.18,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.05,"profit":true},{"date":"2023-12-31","value":9.8,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Revenue	-	344.17%	3834.42%	(8.78%)	(77.94%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":8.98,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.23,"profit":false},{"date":"2023-12-31","value":-2.03,"profit":false}]
Cost of Revenue	-	188.88%	448.11%	17.39%	(86.77%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":42.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":3.88,"profit":true},{"date":"2023-12-31","value":-19.36,"profit":false}]
Gross Profit	-	64.18%	(6907.87%)	(15.46%)	(74.81%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-10762.88,"profit":false},{"date":"2022-12-31","value":-24.09,"profit":false},{"date":"2023-12-31","value":-116.56,"profit":false}]
Gross Margin	-	(63.04%)	(273.03%)	(7.33%)	14.19%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-444.24,"profit":false},{"date":"2021-12-31","value":-1924.16,"profit":false},{"date":"2022-12-31","value":-51.63,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	(401.69%)	(243.32%)	(32.08%)	1603.46%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-25.05,"profit":false},{"date":"2021-12-31","value":-15.17,"profit":false},{"date":"2022-12-31","value":-2,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	(54.60%)	(18644.48%)	(17.28%)	(94.54%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Total Non-Operating Income/Expense	-	(3784.41%)	293.59%	(336.63%)	(54.74%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1289.02,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-114.66,"profit":false},{"date":"2023-12-31","value":-18.64,"profit":false}]
Pre-Tax Income	-	(18.75%)	(10419.75%)	(13.91%)	(90.84%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	59974.63%	(3052.73%)	(25.96%)	(92.73%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-5.09,"profit":false},{"date":"2022-12-31","value":-0.04,"profit":false},{"date":"2023-12-31","value":-0.15,"profit":false}]
Income After Taxes	-	(108.48%)	67622.73%	(8.34%)	(90.14%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.16,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.01,"profit":false},{"date":"2023-12-31","value":-0.13,"profit":false}]

Income From Continuous Operations	-	(108.48%)	67622.73%	(8.34%)	(90.14%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.16,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.01,"profit":false},{"date":"2023-12-31","value":-0.13,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(108.48%)	67613.82%	(8.34%)	(90.14%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.16,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.01,"profit":false},{"date":"2023-12-31","value":-0.13,"profit":false}]

EPS (Diluted)	-	(117.95%)	56600.00%	(6.95%)	(89.47%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.21,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.01,"profit":false},{"date":"2023-12-31","value":-0.16,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	4.28B	1.28B	167.70M	895.30M	1.48B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":29.85,"profit":true},{"date":"2023-06-30","value":3.92,"profit":true},{"date":"2023-09-30","value":20.93,"profit":true},{"date":"2023-12-31","value":34.57,"profit":true}]
Cost of Revenue	693.30M	430.00M	536.30M	659.70M	179.10M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":62.02,"profit":true},{"date":"2023-06-30","value":77.35,"profit":true},{"date":"2023-09-30","value":95.15,"profit":true},{"date":"2023-12-31","value":25.83,"profit":true}]
Gross Profit	3.58B	847.00M	(368.60M)	235.60M	1.30B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":23.63,"profit":true},{"date":"2023-06-30","value":-10.28,"profit":false},{"date":"2023-09-30","value":6.57,"profit":true},{"date":"2023-12-31","value":36.26,"profit":true}]
Gross Margin	83.79%	66.33%	(219.80%)	26.32%	87.89%	[{"date":"2022-12-31","value":95.34,"profit":true},{"date":"2023-03-31","value":75.47,"profit":true},{"date":"2023-06-30","value":-250.08,"profit":false},{"date":"2023-09-30","value":29.94,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	292.10M	118.00M	194.70M	153.70M	701.90M	[{"date":"2022-12-31","value":41.62,"profit":true},{"date":"2023-03-31","value":16.81,"profit":true},{"date":"2023-06-30","value":27.74,"profit":true},{"date":"2023-09-30","value":21.9,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	3.29B	654.40M	(563.30M)	73.10M	526.20M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":19.87,"profit":true},{"date":"2023-06-30","value":-17.11,"profit":false},{"date":"2023-09-30","value":2.22,"profit":true},{"date":"2023-12-31","value":15.98,"profit":true}]
Total Non-Operating Income/Expense	(240.60M)	112.20M	302.20M	145.50M	65.20M	[{"date":"2022-12-31","value":-79.62,"profit":false},{"date":"2023-03-31","value":37.13,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":48.15,"profit":true},{"date":"2023-12-31","value":21.58,"profit":true}]
Pre-Tax Income	3.17B	707.70M	(412.20M)	227.40M	663.20M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":22.31,"profit":true},{"date":"2023-06-30","value":-12.99,"profit":false},{"date":"2023-09-30","value":7.17,"profit":true},{"date":"2023-12-31","value":20.9,"profit":true}]
Income Taxes	893.90M	205.50M	(221.80M)	66.80M	205.30M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":22.99,"profit":true},{"date":"2023-06-30","value":-24.81,"profit":false},{"date":"2023-09-30","value":7.47,"profit":true},{"date":"2023-12-31","value":22.97,"profit":true}]
Income After Taxes	2.28B	502.20M	(190.40M)	160.60M	457.90M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":22.04,"profit":true},{"date":"2023-06-30","value":-8.36,"profit":false},{"date":"2023-09-30","value":7.05,"profit":true},{"date":"2023-12-31","value":20.09,"profit":true}]

Income From Continuous Operations	2.28B	502.20M	(190.40M)	160.60M	457.90M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":22.04,"profit":true},{"date":"2023-06-30","value":-8.36,"profit":false},{"date":"2023-09-30","value":7.05,"profit":true},{"date":"2023-12-31","value":20.09,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	2.28B	502.20M	(190.40M)	160.60M	457.90M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":22.04,"profit":true},{"date":"2023-06-30","value":-8.36,"profit":false},{"date":"2023-09-30","value":7.05,"profit":true},{"date":"2023-12-31","value":20.09,"profit":true}]

EPS (Diluted)	9.26	2.05	(0.79)	0.73	1.90	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":22.14,"profit":true},{"date":"2023-06-30","value":-8.53,"profit":false},{"date":"2023-09-30","value":7.88,"profit":true},{"date":"2023-12-31","value":20.52,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Revenue	-	(70.15%)	(86.87%)	433.87%	65.20%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-16.17,"profit":false},{"date":"2023-06-30","value":-20.02,"profit":false},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":15.03,"profit":true}]
Cost of Revenue	-	(37.98%)	24.72%	23.01%	(72.85%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-153.63,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":93.08,"profit":true},{"date":"2023-12-31","value":-294.69,"profit":false}]
Gross Profit	-	(76.37%)	(143.52%)	(163.92%)	451.74%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-16.91,"profit":false},{"date":"2023-06-30","value":-31.77,"profit":false},{"date":"2023-09-30","value":-36.29,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin	-	(20.85%)	(431.38%)	(111.97%)	233.99%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-8.91,"profit":false},{"date":"2023-06-30","value":-184.36,"profit":false},{"date":"2023-09-30","value":-47.85,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Operating Expenses	-	(59.60%)	65.00%	(21.06%)	356.67%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-16.71,"profit":false},{"date":"2023-06-30","value":18.22,"profit":true},{"date":"2023-09-30","value":-5.9,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	(80.13%)	(186.08%)	(112.98%)	619.84%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-12.93,"profit":false},{"date":"2023-06-30","value":-30.02,"profit":false},{"date":"2023-09-30","value":-18.23,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	(146.63%)	169.34%	(51.85%)	(55.19%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-86.59,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-30.62,"profit":false},{"date":"2023-12-31","value":-32.59,"profit":false}]
Pre-Tax Income	-	(77.69%)	(158.25%)	(155.17%)	191.64%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-40.54,"profit":false},{"date":"2023-06-30","value":-82.57,"profit":false},{"date":"2023-09-30","value":-80.97,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes	-	(77.01%)	(207.93%)	(130.12%)	207.34%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-37.14,"profit":false},{"date":"2023-06-30","value":-100.29,"profit":false},{"date":"2023-09-30","value":-62.76,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes	-	(77.96%)	(137.91%)	(184.35%)	185.12%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-42.11,"profit":false},{"date":"2023-06-30","value":-74.5,"profit":false},{"date":"2023-09-30","value":-99.58,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Income From Continuous Operations	-	(77.96%)	(137.91%)	(184.35%)	185.12%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-42.11,"profit":false},{"date":"2023-06-30","value":-74.5,"profit":false},{"date":"2023-09-30","value":-99.58,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(77.96%)	(137.91%)	(184.35%)	185.12%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-42.11,"profit":false},{"date":"2023-06-30","value":-74.5,"profit":false},{"date":"2023-09-30","value":-99.58,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

EPS (Diluted)	-	(77.86%)	(138.54%)	(192.41%)	160.27%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-48.58,"profit":false},{"date":"2023-06-30","value":-86.44,"profit":false},{"date":"2023-09-30","value":-120.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	560.15M	1.67B	15.07B	21.92B	19.53B	[{"date":"2019-12-31","value":2.56,"profit":true},{"date":"2020-12-31","value":7.6,"profit":true},{"date":"2021-12-31","value":68.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.08,"profit":true}]
Non-current Assets	237.50M	651.72M	758.50M	1.36B	3.48B	[{"date":"2019-12-31","value":6.83,"profit":true},{"date":"2020-12-31","value":18.73,"profit":true},{"date":"2021-12-31","value":21.8,"profit":true},{"date":"2022-12-31","value":39.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	797.65M	2.32B	15.83B	23.28B	23.01B	[{"date":"2019-12-31","value":3.43,"profit":true},{"date":"2020-12-31","value":9.96,"profit":true},{"date":"2021-12-31","value":68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.83,"profit":true}]

Total Liabilities
Current Liabilities	138.14M	606.01M	3.48B	2.95B	2.07B	[{"date":"2019-12-31","value":3.97,"profit":true},{"date":"2020-12-31","value":17.41,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.75,"profit":true},{"date":"2023-12-31","value":59.47,"profit":true}]
Non-current Liabilities	166.01M	340.76M	455.50M	272.90M	689.90M	[{"date":"2019-12-31","value":24.06,"profit":true},{"date":"2020-12-31","value":49.39,"profit":true},{"date":"2021-12-31","value":66.02,"profit":true},{"date":"2022-12-31","value":39.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	304.15M	946.77M	3.94B	3.22B	2.76B	[{"date":"2019-12-31","value":7.73,"profit":true},{"date":"2020-12-31","value":24.05,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.87,"profit":true},{"date":"2023-12-31","value":70.11,"profit":true}]

Total Shareholders' equity
Common Stock	232.30M	246.31M	246.30M	248.60M	248.60M	[{"date":"2019-12-31","value":93.44,"profit":true},{"date":"2020-12-31","value":99.08,"profit":true},{"date":"2021-12-31","value":99.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	(424.83M)	(409.63M)	9.88B	18.83B	19.76B	[{"date":"2019-12-31","value":-2.15,"profit":false},{"date":"2020-12-31","value":-2.07,"profit":false},{"date":"2021-12-31","value":50.01,"profit":true},{"date":"2022-12-31","value":95.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	(5.53M)	1.51B	(3.80M)	(5.30M)	1.22B	[{"date":"2019-12-31","value":-0.37,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.25,"profit":false},{"date":"2022-12-31","value":-0.35,"profit":false},{"date":"2023-12-31","value":80.72,"profit":true}]
Total Shareholders' equity	493.49M	1.37B	11.89B	20.06B	20.25B	[{"date":"2019-12-31","value":2.44,"profit":true},{"date":"2020-12-31","value":6.78,"profit":true},{"date":"2021-12-31","value":58.75,"profit":true},{"date":"2022-12-31","value":99.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	797.65M	2.32B	15.83B	23.28B	23.01B	[{"date":"2019-12-31","value":3.43,"profit":true},{"date":"2020-12-31","value":9.96,"profit":true},{"date":"2021-12-31","value":68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.83,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Total Assets
Current Assets	-	197.58%	804.21%	45.45%	(10.92%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":24.57,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":5.65,"profit":true},{"date":"2023-12-31","value":-1.36,"profit":false}]
Non-current Assets	-	174.41%	16.38%	78.92%	156.36%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":9.39,"profit":true},{"date":"2022-12-31","value":45.25,"profit":true},{"date":"2023-12-31","value":89.65,"profit":true}]
Total Assets	-	190.68%	582.77%	47.05%	(1.17%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":32.72,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.07,"profit":true},{"date":"2023-12-31","value":-0.2,"profit":false}]

Total Liabilities
Current Liabilities	-	338.69%	474.51%	(15.25%)	(29.83%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":71.38,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.21,"profit":false},{"date":"2023-12-31","value":-6.29,"profit":false}]
Non-current Liabilities	-	105.26%	33.67%	(40.09%)	152.80%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":68.89,"profit":true},{"date":"2021-12-31","value":22.04,"profit":true},{"date":"2022-12-31","value":-26.23,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	211.28%	315.84%	(18.13%)	(14.37%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":66.89,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-5.74,"profit":false},{"date":"2023-12-31","value":-4.55,"profit":false}]

Total Shareholders' equity
Common Stock	-	6.03%	(0.00%)	0.93%	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.07,"profit":false},{"date":"2022-12-31","value":15.49,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	(3.58%)	(2512.65%)	90.56%	4.94%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3.95,"profit":false},{"date":"2021-12-31","value":-2774.52,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":5.45,"profit":true}]
Other Stockholders' Equity	-	(27424.20%)	(100.25%)	39.47%	(23092.45%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-69474.64,"profit":false},{"date":"2021-12-31","value":-253.97,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-58500.88,"profit":false}]
Total Shareholders' equity	-	177.99%	766.99%	68.62%	0.95%	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":23.21,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.95,"profit":true},{"date":"2023-12-31","value":0.12,"profit":true}]

Total Liabilities & Shareholders Equity	-	190.68%	582.77%	47.05%	(1.17%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":32.72,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.07,"profit":true},{"date":"2023-12-31","value":-0.2,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	21.92B	20.09B	19.21B	18.75B	19.53B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":91.63,"profit":true},{"date":"2023-06-30","value":87.65,"profit":true},{"date":"2023-09-30","value":85.53,"profit":true},{"date":"2023-12-31","value":89.08,"profit":true}]
Non-current Assets	1.36B	1.99B	3.01B	3.46B	3.48B	[{"date":"2022-12-31","value":39.01,"profit":true},{"date":"2023-03-31","value":57.28,"profit":true},{"date":"2023-06-30","value":86.57,"profit":true},{"date":"2023-09-30","value":99.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	23.28B	22.08B	22.23B	22.21B	23.01B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":94.84,"profit":true},{"date":"2023-06-30","value":95.47,"profit":true},{"date":"2023-09-30","value":95.4,"profit":true},{"date":"2023-12-31","value":98.83,"profit":true}]

Total Liabilities
Current Liabilities	2.95B	1.55B	1.82B	1.81B	2.07B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":52.56,"profit":true},{"date":"2023-06-30","value":61.65,"profit":true},{"date":"2023-09-30","value":61.25,"profit":true},{"date":"2023-12-31","value":70.17,"profit":true}]
Non-current Liabilities	272.90M	262.80M	500.10M	533.20M	689.90M	[{"date":"2022-12-31","value":39.56,"profit":true},{"date":"2023-03-31","value":38.09,"profit":true},{"date":"2023-06-30","value":72.49,"profit":true},{"date":"2023-09-30","value":77.29,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	3.22B	1.81B	2.32B	2.34B	2.76B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":56.26,"profit":true},{"date":"2023-06-30","value":71.94,"profit":true},{"date":"2023-09-30","value":72.6,"profit":true},{"date":"2023-12-31","value":85.63,"profit":true}]

Total Shareholders' equity
Common Stock	248.60M	248.60M	248.60M	248.60M	248.60M	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Retained Earnings	18.83B	19.34B	19.14B	19.31B	19.76B	[{"date":"2022-12-31","value":95.29,"profit":true},{"date":"2023-03-31","value":97.83,"profit":true},{"date":"2023-06-30","value":96.87,"profit":true},{"date":"2023-09-30","value":97.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Other Stockholders' Equity	(5.30M)	1.54B	1.42B	1.22B	1.22B	[{"date":"2022-12-31","value":-0.34,"profit":false},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":91.9,"profit":true},{"date":"2023-09-30","value":79.05,"profit":true},{"date":"2023-12-31","value":79.11,"profit":true}]
Total Shareholders' equity	20.06B	20.27B	19.91B	19.87B	20.25B	[{"date":"2022-12-31","value":98.97,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":98.23,"profit":true},{"date":"2023-09-30","value":98.03,"profit":true},{"date":"2023-12-31","value":99.9,"profit":true}]

Total Liabilities & Shareholders Equity	23.28B	22.08B	22.23B	22.21B	23.01B	[{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-03-31","value":94.84,"profit":true},{"date":"2023-06-30","value":95.47,"profit":true},{"date":"2023-09-30","value":95.4,"profit":true},{"date":"2023-12-31","value":98.83,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Total Assets
Current Assets	-	(8.37%)	(4.34%)	(2.42%)	4.15%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-201.77,"profit":false},{"date":"2023-06-30","value":-104.62,"profit":false},{"date":"2023-09-30","value":-58.28,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	46.85%	51.12%	14.82%	0.60%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":91.64,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":28.99,"profit":true},{"date":"2023-12-31","value":1.18,"profit":true}]
Total Assets	-	(5.16%)	0.66%	(0.08%)	3.60%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-143.27,"profit":false},{"date":"2023-06-30","value":18.45,"profit":true},{"date":"2023-09-30","value":-2.3,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	(47.44%)	17.29%	(0.65%)	14.57%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-274.42,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-3.75,"profit":false},{"date":"2023-12-31","value":84.28,"profit":true}]
Non-current Liabilities	-	(3.70%)	90.30%	6.62%	29.39%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-4.1,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":7.33,"profit":true},{"date":"2023-12-31","value":32.55,"profit":true}]
Total Liabilities	-	(43.74%)	27.87%	0.92%	17.95%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-156.95,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":3.3,"profit":true},{"date":"2023-12-31","value":64.4,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	2.67%	(0.98%)	0.84%	2.37%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-36.93,"profit":false},{"date":"2023-09-30","value":31.46,"profit":true},{"date":"2023-12-31","value":88.95,"profit":true}]
Other Stockholders' Equity	-	(29162.26%)	(8.10%)	(13.99%)	0.08%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-35507972.83,"profit":false},{"date":"2023-06-30","value":-9857.48,"profit":false},{"date":"2023-09-30","value":-17030.57,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Total Shareholders' equity	-	1.05%	(1.77%)	(0.20%)	1.91%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":54.79,"profit":true},{"date":"2023-06-30","value":-92.78,"profit":false},{"date":"2023-09-30","value":-10.45,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	(5.16%)	0.66%	(0.08%)	3.60%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-143.27,"profit":false},{"date":"2023-06-30","value":18.45,"profit":true},{"date":"2023-09-30","value":-2.3,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	(198.54M)	(13.47M)	889.70M	13.58B	5.37B	[{"date":"2019-12-31","value":-1.46,"profit":false},{"date":"2020-12-31","value":-0.1,"profit":false},{"date":"2021-12-31","value":6.55,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":39.56,"profit":true}]

Investing Activities
Net Investing Cash Flow	(77.11M)	(144.85M)	(566.10M)	-	-	[{"date":"2019-12-31","value":-7711500000,"profit":false},{"date":"2020-12-31","value":-14484800000,"profit":false},{"date":"2021-12-31","value":-56610000000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	383.29M	894.73M	94.20M	(1.42B)	(778.60M)	[{"date":"2019-12-31","value":42.84,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":10.53,"profit":true},{"date":"2022-12-31","value":-158.63,"profit":false},{"date":"2023-12-31","value":-87.02,"profit":false}]

Net Change in Cash	107.65M	691.06M	482.50M	12.18B	(2.21B)	[{"date":"2019-12-31","value":0.88,"profit":true},{"date":"2020-12-31","value":5.67,"profit":true},{"date":"2021-12-31","value":3.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-18.15,"profit":false}]

Free Cash Flow
Free Cash Flow	(269.62M)	(98.92M)	735.70M	13.21B	4.67B	[{"date":"2019-12-31","value":-2.04,"profit":false},{"date":"2020-12-31","value":-0.75,"profit":false},{"date":"2021-12-31","value":5.57,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.31,"profit":true}]

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	5YR TREND
Operating Activities
Net Operating Cash Flow	-	(93.21%)	(6703.09%)	1426.06%	(60.44%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-6.54,"profit":false},{"date":"2021-12-31","value":-470.04,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4.24,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	87.83%	290.82%	-	-	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":30.2,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	133.43%	(89.47%)	(1606.69%)	(45.14%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-67.05,"profit":false},{"date":"2022-12-31","value":-1204.12,"profit":false},{"date":"2023-12-31","value":-33.83,"profit":false}]

Net Change in Cash	-	541.93%	(30.18%)	2424.85%	(118.15%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":22.35,"profit":true},{"date":"2021-12-31","value":-1.24,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-4.87,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(63.31%)	(843.73%)	1696.13%	(64.69%)	[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3.73,"profit":false},{"date":"2021-12-31","value":-49.74,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-3.81,"profit":false}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	829.20M	(677.40M)	4.39B	811.20M	850.90M	[{"date":"2022-12-31","value":18.9,"profit":true},{"date":"2023-03-31","value":-15.44,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":18.49,"profit":true},{"date":"2023-12-31","value":19.4,"profit":true}]

Investing Activities
Net Investing Cash Flow	(1.23B)	(1.23B)	(1.23B)	(1.23B)	-	[{"date":"2022-12-31","value":-123220000000,"profit":false},{"date":"2023-03-31","value":-123220000000,"profit":false},{"date":"2023-06-30","value":-123220000000,"profit":false},{"date":"2023-09-30","value":-123220000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	(64.70M)	(291.30M)	(163.40M)	(311.00M)	(12.90M)	[{"date":"2022-12-31","value":-6470000000,"profit":false},{"date":"2023-03-31","value":-29130000000,"profit":false},{"date":"2023-06-30","value":-16340000000,"profit":false},{"date":"2023-09-30","value":-31100000000,"profit":false},{"date":"2023-12-31","value":-1290000000,"profit":false}]

Net Change in Cash	451.40M	(1.73B)	2.02B	(670.80M)	(1.83B)	[{"date":"2022-12-31","value":22.32,"profit":true},{"date":"2023-03-31","value":-85.59,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":-33.16,"profit":false},{"date":"2023-12-31","value":-90.58,"profit":false}]

Free Cash Flow
Free Cash Flow	684.70M	(732.20M)	4.08B	660.00M	660.70M	[{"date":"2022-12-31","value":16.79,"profit":true},{"date":"2023-03-31","value":-17.96,"profit":false},{"date":"2023-06-30","value":100,"profit":true},{"date":"2023-09-30","value":16.19,"profit":true},{"date":"2023-12-31","value":16.2,"profit":true}]

	Dec '22	Mar '23	Jun '23	Sep '23	Dec '23	TREND
Operating Activities
Net Operating Cash Flow	-	(181.69%)	(747.58%)	(81.51%)	4.89%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-3712.58,"profit":false},{"date":"2023-06-30","value":-15275.47,"profit":false},{"date":"2023-09-30","value":-1665.47,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	-	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	350.23%	(43.91%)	90.33%	(95.85%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2023-06-30","value":-12.54,"profit":false},{"date":"2023-09-30","value":25.79,"profit":true},{"date":"2023-12-31","value":-27.37,"profit":false}]

Net Change in Cash	-	(483.52%)	(216.84%)	(133.16%)	173.12%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-279.29,"profit":false},{"date":"2023-06-30","value":-125.25,"profit":false},{"date":"2023-09-30","value":-76.92,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(206.94%)	(656.87%)	(83.81%)	0.11%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-03-31","value":-195112.35,"profit":false},{"date":"2023-06-30","value":-619334.3,"profit":false},{"date":"2023-09-30","value":-79023.89,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	BNTX
Cash Ratio	7.99
Current Ratio	9.43
Quick Ratio	9.26

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BNTX
ROA (LTM)	2.62%
ROE (LTM)	4.62%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BNTX
Debt Ratio Lower is generally better. Negative is bad.	0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.88
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is.	1.14

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BNTX
Trailing PE	21.36
Forward PE	7.04
P/S (TTM)	5.52
P/B	0.97
Price/FCF	32
EV/R	0.95
EV/Ebitda	3.33
PEG	NM

News

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?

The 2024 presidential election is shaping up to be just as exciting and contentious the 2020 contest. That’s because it looks to be a rematch between President Biden and former President Trump. There’s a wildcard thrown in this time with Robert Kennedy Jr. running an independent campaign that could pull voters from both sides. The stock market went on a rollercoaster ride four years ago. A decade-long bull market was brought up short by the pandemic. The S&P 500 lost one-third of its value in a matter of weeks only to make a U-turn and soar higher once more. It wasn’t uncommon to see stocks soar by 1,000% or more. These are the seven top 2020 stocks that didn’t end up crashing and becoming penny stocks . Can they repeat their prized performance from four years ago? Let’s find out! Novavax (NVAX) Source: pixinoo / Shutterstock.com The pandemic, of course, was the defining moment of 2020. Not only for the devastation it caused in our lives but also for the opportunity it created for companies to rise to the challenge.

9 Apr, 2024 a 8:30 pm InvestorPlace

TROP-2 Inhibitors Market to Boost by 2034, Predicts DelveInsight | Key Companies to Look Out – Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech, BiOneCure Therapeutics

New York, USA, April 09, 2024 (GLOBE NEWSWIRE) — TROP-2 Inhibitors Market to Boost by 2034, Predicts DelveInsight | Key Companies to Look Out – Daiichi Sankyo, AstraZeneca, Kelun Biotech, Merck, DualityBio, BioNTech, BiOneCure Therapeutics According to DelveInsight’s analysis, the growth of the TROP-2 Inhibitors market is expected to be mainly driven by increasing incidence, […]

9 Apr, 2024 a 5:00 pm Business Upturn

BioNTech SE Virtual AGM Scheduled for May 2024

Biontech Se Sponsored Adr (BNTX) has released an update. BioNTech SE announces its virtual Annual General Meeting (AGM) for shareholders on May 17,…

8 Apr, 2024 a 9:27 pm TipRanks

BioNTech Reports Promising Cancer Vaccine Data

Biontech Se Sponsored Adr (BNTX) has released an update. BioNTech’s latest three-year follow-up data on its individualized mRNA cancer vaccine, aut…

8 Apr, 2024 a 11:57 am TipRanks

BioNTech SE: Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer

Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122, RO7198457) continue to show polyspecific T cell …

7 Apr, 2024 a 6:10 pm Finanz Nachrichten

Cheaper private Covid jabs may prove to be as expensive, say experts

Exclusive: Multi-dose vials could push up charge per patient, while experts warn high cost could widen inequalities Cheaper private Covid jabs could end up being just as expensive as their pricier alternative because the vaccine must be given in groups of five, experts have warned. Boots and pharmacies that partner with the company Pharmadoctor are offering Pfizer/BioNTech jabs to those not eligible for a free vaccination through the NHS, with the former charging almost £100 a shot. The latter is also offering the latest Novavax jab, a protein-based vaccine, at a cost of about £50. Continue reading…

2 Apr, 2024 a 2:32 pm The Guardian

The 3 Best Bargain Stocks to Buy in Q2 2024

Best bargain stocks to buy is a simple but tricky concept. Whenever shares trade lower than an established multiple, whether that by earnings, sales, book or some other metric, there might be a reason for it. In many cases, it’s not a good one. Let’s face reality here. In the age of the internet, it’s difficult for a well-known publicly traded enterprise to be woefully undervalued. That’s because information is readily available. If the market genuinely believed there was value to be extracted, the shares in question would have likely jumped higher by now. Still, there are thousands upon thousands of opportunities. It’s impossible to pay attention to them all. In that regard, Wall Street can certainly miss a few. With that, below are intriguing ideas for best bargain stocks to buy. BioNTech (BNTX) Source: Palatinate Stock / Shutterstock.com Operating under the biotechnology sector, BioNTech (NASDAQ: BNTX ) develops and commercializes immunotherapies for cancer and other infectious diseases.

31 Mar, 2024 a 7:39 pm InvestorPlace

3 Biotech Stocks to Buy for the Next Bull Run: March 2024

As we step into March 2024, the spotlight is turning towards the biotech sector, with investors searching for biotech stocks to buy. Biotech stocks are ready to soar after a period of under-performance relative to the broader market. With advancements in gene editing, personalized medicine and novel therapeutics, the sector is on the cusp of delivering transformative healthcare solutions. The global biotechnology market is set for remarkable growth . It is forecast to soar from $1 trillion in 2022 to an impressive $3.6 trillion by 2032. This translates to a CAGR of 14%. Demand for innovative treatments and vaccines continues to surge, potentially unlocking exponential growth for well-positioned biotech companies. Given the positive trends, investors can benefit from the rise in biotech stocks. I have identified three biotech stocks to buy that are well-positioned for growth in the next bull run. Vertex Pharmaceuticals (VRTX) Source: Shutterstock Vertex Pharmaceuticals (NASDAQ: VRTX ) is increasingly capturing the attention of growth-focused investors.

26 Mar, 2024 a 10:44 am InvestorPlace

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is BioNTech SE share price today?

BioNTech SE (BNTX) share price today is $87.01

Can Indians buy BioNTech SE shares?

Yes, Indians can buy shares of BioNTech SE (BNTX) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BNTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioNTech SE be purchased?

Yes, you can purchase fractional shares of BioNTech SE (BNTX) via the Vested app. You can start investing in BioNTech SE (BNTX) with a minimum investment of $1.

How to invest in BioNTech SE shares from India?

You can invest in shares of BioNTech SE (BNTX) via Vested in three simple steps:

Click on Sign Up or Invest in BNTX stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in BioNTech SE shares

What is BioNTech SE 52-week high and low stock price?

The 52-week high price of BioNTech SE (BNTX) is $131.52. The 52-week low price of BioNTech SE (BNTX) is $85.21.

What is BioNTech SE price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of BioNTech SE (BNTX) is 20.52

What is BioNTech SE price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioNTech SE (BNTX) is 0.97

What is BioNTech SE dividend yield?

The dividend yield of BioNTech SE (BNTX) is 0.00%

What is the Market Cap of BioNTech SE?

The market capitalization of BioNTech SE (BNTX) is $20.68B

What is BioNTech SE’s stock symbol?

The stock symbol (or ticker) of BioNTech SE is BNTX

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

BioNTech SE, Common Stock

BNTX

NSQ

$87.01

-$1.64

(-1.85%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About BioNTech SE, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

News

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²